Clinical Trials Directory

Trials / Completed

CompletedNCT05198583

EF Intervention in Children With Severe Congenital Heart Disease

Executive Function and Brain Development in Adolescents With Severe Congenital Heart Disease (Teen Heart Study)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
42 (actual)
Sponsor
University Children's Hospital, Zurich · Academic / Other
Sex
All
Age
10 Years – 12 Years
Healthy volunteers
Not accepted

Summary

Survival rates of children with severe congenital heart disease (CHD) have increased with ongoing medical progress over the past decades. However, many children with CHD face academic challenges during adolescence, which are associated with executive dysfunction. Executive functions (EF), higher-order cognitive processes allowing goal-directed behavior, can be particularly affected in children with CHD. To improve EF in affected children, a specific EF intervention has been developed. The intervention lasts a total of 8 weeks and is structured in 3 modules. The first module consists of a weekly strategy training in which problems resulting from executive dysfunction are addressed. Online games form the second module. These are games implemented online to promote EF through play. The third module is also based on games: The families receive several board games to play together at home. This third module is voluntary. This intervention is tested on its feasibility. As the intervention was built in a patient centered manner, we expect it to be feasible, showing in a high adherence rate and satisfaction.

Conditions

Interventions

TypeNameDescription
OTHERE-FitThe intervention lasts a total of 8 weeks and is structured in 3 modules. The first module consists of a weekly strategy training in which problems resulting from executive dysfunction are addressed. Online games form the second module. These are games implemented online to promote EF through play. The third module is also based on games: The families receive several board games to play together at home. This third module is voluntary.

Timeline

Start date
2022-07-01
Primary completion
2024-05-24
Completion
2024-08-14
First posted
2022-01-20
Last updated
2024-12-20

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT05198583. Inclusion in this directory is not an endorsement.